期刊文献+

盐酸拉贝洛尔联合综合干预模式对妊娠高血压患者妊娠结局的影响 被引量:6

下载PDF
导出
摘要 目的探讨盐酸拉贝洛尔联合综合干预模式对妊娠高血压患者妊娠结局的影响。方法随机选取收治的126例妊娠高血压患者,采用随机数字表法分为试验组和对照组。试验组采用盐酸拉贝洛尔联合综合干预的模式对患者进行治疗,对照组采用盐酸拉贝洛尔联合常规护理模式。对比治疗前后两组患者收缩压、舒张压以及24 h尿蛋白变化、母婴结局以及患者满意度。结果两组患者经过治疗后,收缩压、舒张压和24 h尿蛋白水平都有所降低,试验组较对照组更加明显;试验组护理满意度也远远高于对照组;试验组产后出血、胎儿窘迫、新生儿窒息、终止妊娠以及胎盘早剥发生率均明显低于对照组(3.17%vs.15.87%,4.76%vs.19.05%,1.59%vs.12.70%,0.00%vs.9.52%,4.76%vs.15.87%),各组数据比较,差异均具有统计学意义(P<0.05)。结论采用盐酸拉贝洛尔联合综合干预模式以及盐酸拉贝洛尔联合常规护理均可以降低患者收缩压、舒张压和24 h尿蛋白水平,但是前者效果更加显著,同时在很大程度上降低母婴结局各种危急状况发生率,提高患者满意度,积极作用大。
作者 胡俊
出处 《中国处方药》 2015年第9期108-109,共2页 Journal of China Prescription Drug
  • 相关文献

参考文献12

二级参考文献64

  • 1袁蜀豫,陈炜卿,朱小软,路照鑫,邱华豪.妊高征发病相关因素及对母婴健康的影响[J].中国妇幼保健,2006,21(1):44-45. 被引量:20
  • 2乐杰,谢幸,等主编.妇产科学[M].第7版.北京:人民卫生出版社,2009.241.
  • 3Jim B.Sharma S,Kebede T,et al.Hypertension in pregnancy:acomprehensive update[J].Cardiol Rev,2010,18(4):178-189.
  • 4乐杰.妇产科学[M].6版.北京:人民卫生出版社,1980:398.
  • 5Siddiqui AH,Irani RA,Zhang W,et al.Angiotensin receptoragonistic autoantibody-mediated soluble fms-like tyrosinekinase-1 induction contributes to impaired adrenal vasculature anddecreased aldosterone production in preeclampsia[J].Hypertension,2013,61(2):472-429.
  • 6Mazzuca MQ, Li W, Reslan OM, et al. Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy[ J]. Hypertension ,2014,64 ( 3 ) :632 - 643.
  • 7Tripodi A. D-dimer testing in laboratory practice[ J]. Clin Chem ,2011, 57(9) :1256 - 1262.
  • 8James H, Fischer G E, Sarto J H. Influence of Gestational Age and Body Weight on the Pharmacokinetics of Labetalol in Pregnancy [ J]. Clinical Pharmacokinetics ,2014,53 (4) :373 - 383.
  • 9Morales-Vidal S,Schneck MJ, Flaster MS, et al. Strokeand pregnancy-induced hypertensive syndromes [ J ].Women7s Health,2011,7(3) :283-292.
  • 10Liu A, Carlsson E,Nilsson S, et al. Hypertensive diseaseof pregnancy is associated with decreased risk for respira-tory distress syndrome in moderate preterm neonates[J].Hypertension in Pregnancy,2013,32 (2): 169-177.

共引文献201

同被引文献74

  • 1王宏鑫,王振国,赵琳.盐酸川芎嗪注射液联合硫酸镁和拉贝洛尔治疗妊娠高血压综合征的临床研究[J].现代药物与临床,2020,35(1):43-47. 被引量:20
  • 2冯年平,屠锡德.盐酸拉贝洛尔缓释片及其药动学研究[J].中国药科大学学报,1996,27(1):13-15. 被引量:5
  • 3Dashevsky A, Mohamad A. Development of pulsatile muhiplarticulate drug delivery system coated with aqueous dispersion Aquacoat (R) ECD [J]. International journal of pharmaceutics, 2006,318 (1-2) : 124-131.
  • 4Jagdale SC, Chede SM, Gulwady R,et al. Pulsatile Multiparticulate Drug Delivery System for Metoprolol Succinate. Archives of Pharmacal Research [J]. 2011,34(3):369-376.
  • 5Hung SF, Hsieh CM, Chen YC, et al. Formulation and process optimization of muhiparticulate pulsatile system delivered by osmotic pressure-activated rupturable membrane [J]. International journal of pharmaceutics, 2015,480(1-2) : 15-26.
  • 6Chaudhary SS,Patel HK,Parejiya PB,et aL Chronomodulated drug delivery system of urapidil for the treatment of hypertension[J]. Int J Pharm Investig,2015,5 (2) : 107- 113.
  • 7Yadav D, Survase S,Kumar N. Dual coating of swellable and rupturable polymers on Glipizide loaded MCC pellets for pulsatile delivery: Formulation design and in vitro evaluation [J]. International Journal of Pharmaceutics, 2011,419(1-2) : 121-130.
  • 8Sungthongjeen S,Puttipipatkhachorn S,Paeratakul O,et al. Development of pulsatile release tablets with swelling and rupturable layers [J]. Journal of controlled release, 2004,95(2) : 147-159.
  • 9Bussemer T, Bodmeier R. Formulation parameters affecting the performance of coated gelatin capsules with pulsatile release profiles [J]. International Journal of Pharmaceutics, 2003,267(1-2) : 59-68.
  • 10刘耀,刘松青.挤出-滚圆法制备微丸的研究进展[J].中国药学杂志,2008,43(6):401-405. 被引量:23

引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部